DMD and Duchenne muscular dystrophy: In the Phase 1 trial, males between the ages of 4 and 8 years who had been diagnosed with DMD based on their clinical phenotype and any DMD mutation were eligible to participate if they could walk on their own, with or without the aid of support, and if they had not taken any corticosteroids in the six months before to the screening.